Asthma and lower airway diseaseUse of asthma medication during pregnancy and risk of specific congenital anomalies: A European case-malformed control study
Key words
Abbreviations used
Cited by (0)
Supported by the European Union under the Seventh Framework Programme (grant agreement HEALTH-F5-2011-260598). The funding source had no involvement in the study.
Disclosure of potential conflict of interest: E. Garne, A. V. Hansen, L. Zaupper, I. Barisic, K. Klungsøyr, M. O'Mahony, V. Nelen, A. Pierini, and H. de Walle have received research support from the European Union Framework 7 Programme. M. Gatt has received research support from the Ministry for Health, Directorate for Health Information and Research. A. J. Neville has received travel support from EUROCAT, is a member of the DIFK Cooper expert panel on isotrentinoin, and has received research support from Euromedicat (a partner is the FP7 project) and EUROMEDISAFE. D. Tucker has received travel support from EuroMedicat. A. Wiesel has received consultancy fees from Geburtenregister Mainzer Modell and has received travel support from EuroMedicat. M. Loane has received research and travel support from the European Union Framwork 7 Programme. H. Dolk has received research support from the European Commission Framework 7 and GlaxoSmithKline. The rest of the other authors declare they have no relevant conflicts of interest.